Archive new TB medicines

World TB Day 2016: Celebrating Successes and Lessons Learned in Swaziland

In 2012, bedaquiline was conditionally approved by the U.S. Food and Drug Administration for the treatment of drug-resistant tuberculosis (TB), making it the first new TB drug to enter the market in more than 40 years. With the rise of multidrug-resistant and extensively drug-resistant TB leaving patients with fewer treatment options, the approval of bedaquiline … Read more

, , , , ,